The DOI matches its Crossref record; 58 of the 60 references it cites were found in a registry or an index.
Anterior Pituitary Hypoplasia and Dwarfism in Mice Lacking the Dopamine Transporter
Open accessAbstract
Deletion of the dopamine transporter (DAT) results in increased dopaminergic tone, anterior pituitary hypoplasia, dwarfism, and an inability to lactate. DAT elimination alters the spatial distribution and dramatically reduces the numbers of lactotrophs and somatotrophs in the pituitary. Despite having normal circulating levels of growth hormone and prolactin in blood, hypoplastic glands from DAT-/- mice fail to respond to secretagog stimulation. The effects of DAT deletion on pituitary function result from elevated DA levels that down-regulate the lactotroph D2 DA receptors and depress hypothalamic growth hormone-releasing hormone content. These results reveal an unexpected and important role or DA in the control of developmental events in the pituitary gland and assign a critical role for hypothalamic DA reuptake in regulating these events.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The excess dopamine is dispersed by blood flow, reaches the pituitary, and retards growth in these animals.”
From Effects of Stimulant Medication on Growth Rates Across 3 Years in the MTA Follow-up (2007) · cites this paper as Bosse et al., 1997
In the citing paper
“Studies of mice (Bosse et al., 1997) that lack the dopamine transporter show that high levels of dopamine occur in the hypothalamus as well as the striatum.”
From Effects of Stimulant Medication on Growth Rates Across 3 Years in the MTA Follow-up (2007) · cites this paper as Bosse et al., 1997
Citations
Cites
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,515
Fraker, P. J., & Speck, J. C. (1978) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(78)91322-0 · Cited by 4,553
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476
Self-citationGrowth Hormone-Releasing Factor from a Human Pancreatic Tumor That Caused Acromegaly
Guillemin, R., Brazeau, P., Böhlen, P., Esch, F. S., LING, N. C., & Wehrenberg, W. B. (1982) · Science · doi:10.1126/science.6812220 · Cited by 1,292
Li, S., Crenshaw, E. B., Rawson, E. J., Simmons, D. M., Swanson, L. W., & Rosenfeld, M. G. (1990) · Nature · doi:10.1038/347528a0 · Cited by 1,196
Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour
Rivier, J., Spiess, J., Thorner, M. O., & Vale, W. (1982) · Nature · doi:10.1038/300276a0 · Cited by 1,102
Neurotransmitter Transporters: Recent Progress
Amara, S., & Kuhar, M. J. (1993) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.16.030193.000445 · Cited by 1,088
A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype
Ingraham, H. A., Chen, R., Mangalam, H. J., Elsholtz, H. P., Flynn, S. E., Lin, C. R., Simmons, D. M., Swanson, L. W., & Rosenfeld, M. G. (1988) · Cell · doi:10.1016/0092-8674(88)90038-4 · Cited by 978
Sornson, M. W., Wu, W., Dasen, J. S., Flynn, S. E., Norman, D. J., O’Connell, S. M., Gukovsky, I., Carrière, C., Ryan, A. K., Miller, A. P., et al. (1996) · Nature · doi:10.1038/384327a0 · Cited by 786
Dopamine: A Prolactin-Inhibiting Hormone*
Ben‐Jonathan, N. (1985) · Endocrine Reviews · doi:10.1210/edrv-6-4-564 · Cited by 739
Research works printed but not linked: 2
- Elsholtz, 1991, Inhibitory control of prolactin and Pit-1/GHF1 gene promoters by dopamine, Proc. Natl. Acad. Sci. USA, 266, 22919
- Fumagalli, 1996, Expression of mRNA coding for the serotonin transporter in aged vs, young brain, 719, 225
Cited by
Sorted by citations
Prolactin: structure, function, and regulation of secretion
Freeman, M. E., Kanyicska, B., Lerant, A., & Nagy, G. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.4.1523 · Cited by 2,457
Dopamine as a Prolactin (PRL) Inhibitor
Ben-Jonathan, N., & Hnasko, R. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.6.0451 · Cited by 983
Role of Serotonin in the Paradoxical Calming Effect of Psychostimulants on Hyperactivity
Gainetdinov, R. R., Wetsel, W. C., Jones, S. R., Levin, E. D., Jaber, M., & Caron, M. G. (1999) · Science · doi:10.1126/science.283.5400.397 · Cited by 885
Self-citationDopaminergic Role in Stimulant-Induced Wakefulness
Wisor, J. P., Nishino, S., Sora, I., Uhl, G. R., Mignot, E. J.-M., & Edgar, D. M. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01787.2001 · Cited by 779
Neuroendocrine Control of Growth Hormone Secretion
Müller, E. E., Locatelli, V., & Cocchi, D. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.2.511 · Cited by 635
Mechanisms of Amphetamine Action Revealed in Mice Lacking the Dopamine Transporter
Jones, S. R., Gainetdinov, R. R., Wightman, R. M., & Caron, M. G. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-06-01979.1998 · Cited by 626
Self-citationHyperdopaminergic mutant mice have higher "wanting" but not "liking" for sweet rewards
Peciña, S., Cagniard, B., Berridge, K. C., Aldridge, J. W., & Zhuang, X. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-28-09395.2003 · Cited by 551
What Can We Learn from Rodents about Prolactin in Humans?
Ben‐Jonathan, N., LaPensee, C. R., & LaPensee, E. W. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0017 · Cited by 527
Hyperactivity and impaired response habituation in hyperdopaminergic mice
Zhuang, X., Oosting, R. S., Jones, S. R., Gainetdinov, R. R., Miller, G. W., Caron, M. G., & Hen, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1982 · Cited by 500
Self-citationSora, I., Hall, F. S., Andrews, A. M., Itokawa, M., Li, X.-F., Wei, H.-B., Wichems, C. H., Lesch, K., Murphy, D. L., & Uhl, G. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091039298 · Cited by 474
Monoamine Transporters: From Genes to Behavior
Gainetdinov, R. R., & Caron, M. G. (2003) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.050802.112309 · Cited by 398
Self-citationMolecular Physiology of Pituitary Development: Signaling and Transcriptional Networks
Zhu, X., Gleiberman, A. S., & Rosenfeld, M. G. (2007) · Physiological Reviews · doi:10.1152/physrev.00006.2006 · Cited by 365
60 YEARS OF NEUROENDOCRINOLOGY: The hypothalamo-prolactin axis
Grattan, D. R. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0213 · Cited by 379
The Family of Na+/Cl− Neurotransmitter Transporters
Nelson, N. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71051785.x · Cited by 358
Effects of Stimulant Medication on Growth Rates Across 3 Years in the MTA Follow-up
SWANSON, J. M., ELLIOTT, G. R., GREENHILL, L. L., WIGAL, T., ARNOLD, L. E., VITIELLO, B., HECHTMAN, L., EPSTEIN, J. N., PELHAM, W. E., ABIKOFF, H. B., et al. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3180686d7e · Cited by 323
Self-citationNeurotransmitter transporters as molecular targets for addictive drugs
Amara, S. G., & Sonders, M. S. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00068-4 · Cited by 288
Hoffman, B. J., Hansson, S. R., Mezey, É., & Palkovits, M. (1998) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1998.0168 · Cited by 276
Stimulant-Related Reductions of Growth Rates in the PATS
SWANSON, J., GREENHILL, L., WIGAL, T., KOLLINS, S., STEHLI, A., DAVIES, M., CHUANG, S., VITIELLO, B., SKROBALA, A., POSNER, K., et al. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000235075.25038.5a · Cited by 264
Gainetdinov, R. R., Jones, S. R., Fumagalli, F., Wightman, R. M., & Caron, M. G. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00063-5 · Cited by 263
Self-citationLoss of autoreceptor functions in mice lacking the dopamine transporter
Jones, S. R., Gainetdinov, R. R., Hu, X., Cooper, D., Wightman, R. M., White, F. J., & Caron, M. G. (1999) · Nature Neuroscience · doi:10.1038/10204 · Cited by 251
Self-citationFunctional hyperdopaminergia in dopamine transporter knock-out mice
Gainetdinov, R. R., Jones, S. R., & Caron, M. G. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00122-5 · Cited by 237
Self-citationBehavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice
Spielewoy, C., Roubert, C., Hamon, M., Nosten‐Bertrand, M., Betancur, C., & Bruno Giros, A. (2000) · Behavioural Pharmacology · doi:10.1097/00008877-200006000-00011 · Cited by 228
Absence of MPTP-Induced Neuronal Death in Mice Lacking the Dopamine Transporter
Bézard, E., Gross, C. E., Fournier, M.-C., Doveró, S., Bloch, B., & Jaber, M. (1999) · Experimental Neurology · doi:10.1006/exnr.1998.6995 · Cited by 227
Self-citationCocaine, reward, movement and monoamine transporters
Uhl, G. R., Hall, F. S., & Sora, I. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4000964 · Cited by 222
Haenisch, B., & Bönisch, H. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.12.002 · Cited by 215
Leo, D., Sukhanov, I., Zoratto, F., Illiano, P., Caffino, L., Sanna, F., Messa, G., Emanuele, M., Esposito, A., Dorofeikova, M., et al. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.1931-17.2018 · Cited by 209
Self-citationSaiardi, A., Bozzi, Y., Baik, J., & Borrelli, E. (1997) · Neuron · doi:10.1016/s0896-6273(00)80352-9 · Cited by 202
Genetic animal models: focus on schizophrenia
Gainetdinov, R. R., Mohn, A. R., & Caron, M. G. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01886-5 · Cited by 201
Self-citationWestphal, C. H., Muller, L., Zhou, A., Zhu, X., Bonner‐Weir, S., Schambelan, M., Steiner, D. F., Lindberg, I., & Leder, P. (1999) · Cell · doi:10.1016/s0092-8674(00)80579-6 · Cited by 193
Animal models of attention-deficit hyperactivity disorder.
Davids, E., Zhang, K., Tarazi, F. I., & Baldessarini, R. J. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00274-6 · Cited by 250
Tonic Dopamine Modulates Exploitation of Reward Learning
Beeler, J. A., Daw, N. D., Frazier, C. R. M., & Zhuang, X. (2010) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2010.00170 · Cited by 183
Dopamine and addiction: what have we learned from 40 years of research
Solinas, M., Belujon, P., Fernagut, P., Jaber, M., & Thiriet, N. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1957-2 · Cited by 163
Self-citationHow many homeobox genes does it take to make a pituitary gland?
Watkins‐Chow, D. E., & Camper, S. A. (1998) · Trends in Genetics · doi:10.1016/s0168-9525(98)01476-0 · Cited by 155
Atypical Antipsychotics and Pituitary Tumors: A Pharmacovigilance Study
Szarfman, A., Tonning, J. M., Levine, J. G., & Doraiswamy, P. M. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.26.6.748 · Cited by 144
Plomin, R. J., & Crabbe, J. C. (2000) · Psychological Bulletin · doi:10.1037/0033-2909.126.6.806 · Cited by 145
Dopamine Neuronal Transport Kinetics and Effects of Amphetamine
Jones, S. R., Joseph, J. D., Barak, L. S., Caron, M. G., & Wightman, R. M. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0732406.x · Cited by 141
Self-citationKuroda, K. O., Tachikawa, K., Yoshida, S., Tsuneoka, Y., & Numan, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.02.008 · Cited by 139
Murphy, D. L., Uhl, G. R., Holmes, A., Ren‐Patterson, R. F., Hall, F. S., Sora, I., Detera‐Wadleigh, S. D., & Lesch, K. (2003) · Genes Brain & Behavior · doi:10.1046/j.1601-1848.2003.00049.x · Cited by 129
Monoamine transporter pharmacology and mutant mice
Gainetdinov, R. R., Sotnikova, T. D., & Caron, M. G. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02044-8 · Cited by 126
Self-citationAnimal models concerning the role of dopamine in attention-deficit hyperactivity disorder
van der Kooij, M. A., & Glennon, J. C. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.12.002 · Cited by 128
Ralph, R. J., Paulus, M. P., Zhuang, X., Hen, R., & Geyer, M. A. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01489-0 · Cited by 119
Lavoie, J., Illiano, P., Sotnikova, T. D., Gainetdinov, R. R., Beaulieu, J., & Hébert, M. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.11.024 · Cited by 119
Self-citationMazei‐Robison, M. S., Couch, R. S., Shelton, R. C., Stein, M. A., & Blakely, R. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.08.003 · Cited by 116
Vitiello, B. (2008) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2007.11.010 · Cited by 113
Viggiano, D., Ruocco, L. A., & Sadile, A. G. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.08.006 · Cited by 110
Mullis, P. E. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01797 · Cited by 109
Cinque, S., Zoratto, F., Poleggi, A., Leo, D., Cerniglia, L., Cimino, S., Tambelli, R., Alleva, E., Gainetdinov, R. R., Giovanni Laviola, A., et al. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00043 · Cited by 107
Self-citationLyons, D. J., Horjales-Araújo, E., & Broberger, C. (2010) · Neuron · doi:10.1016/j.neuron.2009.12.024 · Cited by 105
Reiter, E. O. (2007) · Time to knit · doi:10.1016/b978-1-4160-2911-3.50025-x · Cited by 101
Iaccarino, C., Samad, T. A., Mathis, C., Kercret, H., Picetti, R., & Borrelli, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222319599 · Cited by 99
Ugrumov, M. V. (2009) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2009.08.004 · Cited by 97
Dopamine D2 Receptor Gene Expression in Human Adenohypophysial Adenomas
Ştefăneanu, L., Kovács, K., Horváth, É., Buchfelder, M., Fahlbusch, R., & Lancranjan, I. (2001) · Endocrine · doi:10.1385/endo:14:3:329 · Cited by 97
Santosh, P. J., & Taylor, E. (2000) · European Child & Adolescent Psychiatry · doi:10.1007/s007870070017 · Cited by 94
A model for the development of the hypothalamic–pituitary axis: transcribing the hypophysis
Kioussi, C., Carrière, C., & Rosenfeld, M. G. (1999) · Mechanisms of Development · doi:10.1016/s0925-4773(98)00229-9 · Cited by 91
Fernagut, P., Chalon, S., Diguet, E., Guilloteau, D., Tison, F., & Jaber, M. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00778-9 · Cited by 91
Self-citationGrattan, D. R., Xu, J., McLachlan, M. J., Kokay, I. C., Bunn, S. J., Hovey, R. C., & Davey, H. W. (2001) · Endocrinology · doi:10.1210/endo.142.9.8385 · Cited by 85
Dopamine transporter mutant animals: a translational perspective
Efimova, E. V., Gainetdinov, R. R., Budygin, E. A., & Sotnikova, T. D. (2016) · Journal of Neurogenetics · doi:10.3109/01677063.2016.1144751 · Cited by 86
Self-citationKonstandi, M., Johnson, E., Lang, M. A., Malamas, M., & Μαρσέλος, Μ. (2000) · Pharmacological Research · doi:10.1006/phrs.1999.0597 · Cited by 79
Bliziotes, M. M., McLoughlin, S. W., Gunness, M. E., Fumagalli, F., Jones, S. R., & Caron, M. G. (2000) · Bone · doi:10.1016/s8756-3282(99)00232-x · Cited by 81
Self-citationDopamine transporter mutant mice in experimental neuropharmacology
Gainetdinov, R. R. (2007) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0216-0 · Cited by 79
Self-citationMorice, É., Denis, C., Bruno Giros, A., & Nosten‐Bertrand, M. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03465.x · Cited by 75
Dopamine transporter‐dependent and ‐independent actions of trace amine β‐phenylethylamine
Sotnikova, T. D., Budygin, E. A., Jones, S. R., Dykstra, L., Caron, M. G., & Gainetdinov, R. R. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02721.x · Cited by 74
Self-citationTaste uncoupled from nutrition fails to sustain the reinforcing properties of food
Beeler, J. A., McCutcheon, J. E., Cao, Z. F. H., Murakami, M., Alexander, E. R., Roitman, M. F., & Zhuang, X. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08167.x · Cited by 73
The dopamine transporter role in psychiatric phenotypes
Salatino‐Oliveira, A., Rohde, L. A., & Hutz, M. H. (2017) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32578 · Cited by 73
Transgenic and knock‐out mouse pups: the growing need for behavioral analysis
Branchi, I., & Ricceri, L. (2002) · Genes Brain & Behavior · doi:10.1034/j.1601-183x.2002.10301.x · Cited by 71
Nonproliferative and Proliferative Lesions of the Rat and Mouse Endocrine System
Braendli-Baiocco, A., Balme, E., Bruder, M. C., Chandra, S. A. M., Hellmann, J., Hoenerhoff, M. J., Kambara, T., Landes, C., Lenz, B. F., Mense, M. G., et al. (2018) · Journal of Toxicologic Pathology · doi:10.1293/tox.31.1s · Cited by 70
Antipsychotic Drug Responsiveness and Dopamine Receptor Signaling; Old Players and New Prospects
Rampino, A., Marakhovskaia, A., Soares-Silva, T., Torretta, S., Veneziani, F., & Beaulieu, J. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00702 · Cited by 72
Dissociation of Prolactin Secretion from Tuberoinfundibular Dopamine Activity in Late Pregnant Rats
Andrews, Z. B., Kokay, I. C., & Grattan, D. R. (2001) · Endocrinology · doi:10.1210/endo.142.6.8196 · Cited by 67
Mereu, M., Contarini, G., Buonaguro, E. F., Latte, G., Managò, F., Iasevoli, F., de Bartolomeis, A., & Papaleo, F. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.04.037 · Cited by 69
Psychostimulants and monoamine transporters: upsetting the balance
Elliott, J. M., & Beveridge, T. J. R. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.09.005 · Cited by 65
Cross-species assessments of motor and exploratory behavior related to bipolar disorder
Henry, B. L., Minassian, A., Young, J. W., Paulus, M. P., Geyer, M. A., & Perry, W. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.04.002 · Cited by 65
Genetic Defects of the Growth Hormone–Insulin-like Growth Factor Axis
López‐Bermejo, A., Buckway, C. K., & Rosenfeld, R. G. (2000) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(99)00226-x · Cited by 63
Dopamine Transporters Participate in the Physiological Regulation of Prolactin
DeMaria, J. E., Nagy, G. M., Lerant, A. A., Fekete, M. I. K., Levenson, C. W., & Freeman, M. E. (2000) · Endocrinology · doi:10.1210/endo.141.1.7281 · Cited by 63
Laurent, V., Kimble, A., Peng, B. W., Zhu, P., Pintar, J. E., Steiner, D. F., & Lindberg, I. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261715099 · Cited by 61
Psychotropic and neurotropic activity
Vogel, H. G., & Vogel, W. H. (1997) · Springer eBooks · doi:10.1007/978-3-662-03333-3_5 · Cited by 61
Altered Neurocircuitry in the Dopamine Transporter Knockout Mouse Brain
Zhang, X., Bearer, E. L., Boulat, B., Hall, F. S., Uhl, G. R., & Jacobs, R. E. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011506 · Cited by 63
Sarkar, D. K., Chaturvedi, K., Oomizu, S., Boyadjieva, N. I., & Chen, C. P. (2005) · Endocrinology · doi:10.1210/en.2005-0430 · Cited by 60
Genesis of Prolactinomas: Studies Using Estrogen-Treated Animals
Sarkar, D. K. (2006) · KARGER eBooks · doi:10.1159/000094307 · Cited by 59
Kavelaars, A., Cobelens, P. M., Teunis, M., & Heijnen, C. J. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.01.004 · Cited by 58
TIDAL WAVES: Network mechanisms in the neuroendocrine control of prolactin release
Lyons, D. J., & Broberger, C. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.02.001 · Cited by 65
d -Amphetamine responses in catechol-O-methyltransferase (COMT) disrupted mice
Huotari, M., Garcia-Horsman, A., Karayiorgou, M., Gogos, J. A., & Männistö, P. T. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1627-3 · Cited by 56
Sairenji, T. J., Ikezawa, J., Kaneko, R., Masuda, S., Uchida, K., Takanashi, Y., Masuda, H., Sairenji, T., Amano, I., Takatsuru, Y., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1621196114 · Cited by 55
Nuclear Orphan Receptor Nurr1 Directly Transactivates the Osteocalcin Gene in Osteoblasts
Pirih, F. Q. M., Tang, A., Ozkurt, I. C., Nervina, J. M., & Tetradis, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405677200 · Cited by 52
Physiological role of salsolinol
Tóth, B. E., Bodnár, I., Homicskó, K., Fülöp, F., Fekete, M. I. K., & Nagy, G. M. (2002) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(02)00216-7 · Cited by 50
μ-Opioid receptor variants and dopaminergic sensitivity in alcohol withdrawal
Smolka, M. N., Sander, T., Schmidt, L. G., Samochowiec, J., Rommelspacher, H., Gscheidel, N., Wendel, B., & Hoehe, M. R. (1999) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(99)00017-7 · Cited by 50
Fox, M. A., Panessiti, M., Hall, F. S., Uhl, G. R., & Murphy, D. L. (2013) · Psychopharmacology · doi:10.1007/s00213-013-2988-x · Cited by 49
Banihashemi, B., & Albert, P. R. (2002) · Molecular Endocrinology · doi:10.1210/me.2001-0220 · Cited by 48
Reduced tumor growth in a mouse model of schizophrenia, lacking the dopamine transporter
Asada, M., Ebihara, S., Numachi, Y., Okazaki, T., Yamanda, S., Ikeda, K., Yasuda, H., Sora, I., & Arai, H. (2008) · International Journal of Cancer · doi:10.1002/ijc.23562 · Cited by 47
Kobayashi, M., Nakatani, T., Koda, T., Matsumoto, K., Ozaki, R., Mochida, N., Takao, K., Miyakawa, T., & Matsuoka, I. (2014) · Molecular Brain · doi:10.1186/1756-6606-7-12 · Cited by 46
Richter, F., Gabby, L. C., McDowell, K. A., Mulligan, C. K., Rosa, K. D. L., Sioshansi, P. C., Mortazavi, F., Cely, I., Ackerson, L. C., Tsan, L., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.11.015 · Cited by 46
Development of Hyperactivity and Anxiety Responses in Dopamine Transporter-Deficient Mice
Carpenter, A. C., Saborido, T. P., & Stanwood, G. D. (2012) · Developmental Neuroscience · doi:10.1159/000336824 · Cited by 46
Rickhag, M., Herborg, F., Sørensen, G., Strandfelt, K. N., Andresen, B., Gotfryd, K., Madsen, K. L., Klewe, I. V., Ammendrup‐Johnsen, I., Eriksen, J., et al. (2013) · Nature Communications · doi:10.1038/ncomms2568 · Cited by 45
Neuroanatomical Phenotyping in the Mouse: The Dopaminergic System
Zeiss, C. J. (2005) · Veterinary Pathology · doi:10.1354/vp.42-6-753 · Cited by 45
Dopamine Autoreceptor Regulation of a Hypothalamic Dopaminergic Network
Stagkourakis, S., Kim, H., Lyons, D. J., & Broberger, C. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.03.062 · Cited by 43
The mood stabilizer valproic acid opposes the effects of dopamine on circadian rhythms
Landgraf, D., Joiner, W. J., McCarthy, M. J., Kießling, S., Barandas, R., Young, J. W., Cermakian, N., & Welsh, D. K. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.03.047 · Cited by 44
Altered Corticostriatal Neurotransmission and Modulation in Dopamine Transporter Knock-Down Mice
Wu, N., Cepeda, C., Zhuang, X., & Levine, M. S. (2007) · Journal of Neurophysiology · doi:10.1152/jn.00971.2006 · Cited by 43
Brain Neurons Partly Expressing Dopaminergic Phenotype
Ugrumov, M. V. (2013) · Advances in pharmacology · doi:10.1016/b978-0-12-411512-5.00004-x · Cited by 39
Gautam, D., Jeon, J., Starost, M. F., Han, S., Hamdan, F. F., Cui, Y., Parlow, A. F., Gavrilova, O., Szalayova, I., Mezey, É., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900977106 · Cited by 40
Benveniste, H., Fowler, J. S., Rooney, W. D., Ding, Y., Baumann, A. L., Moller, D. H., Du, C., Backus, W. W., Logan, J., Carter, P., et al. (2005) · PubMed · Cited by 39
Dopamine Release Dynamics in the Tuberoinfundibular Dopamine System
Stagkourakis, S., Dunevall, J., Taleat, Z., Ewing, A. G., & Broberger, C. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.2339-18.2019 · Cited by 36
Metadata
- Authors
- Bossé, R., Fumagalli, F., Jaber, M., Giros, B., Gainetdinov, R. R., Wetsel, W. C., Missale, C., & Caron, M. G.
- Affiliations
- Howard Hughes Medical Institute (US)
- Duke Medical Center (US)
- Corresponding author
- Caron, Marc G
- ORCID
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 1997-07
- Volume
- 19
- Issue
- 1
- Pages
- 127-138
- ISSN
- 0896-6273 (ISSN-L)
- OpenAlex
- W1990625891
- Cited by
- 203
- References
- 60
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2023: 2 · 2022: 3 · 2021: 4 · 2020: 4 · 2019: 4 · 2018: 4 · 2017: 6 · 2016: 5 · 2015: 4 · 2014: 5 · 2013: 9 · 2012: 8
- FWCI
- 10.42
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Neuron (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- dopamine transporter, anterior pituitary hypoplasia, dwarfism, lactotrophs, somatotrophs, growth hormone, prolactin, dopamine D2 receptor, growth hormone-releasing hormone, hypothalamus, lactation, pituitary development, dopamine reuptake
- MeSH terms
- Animals, Carrier Proteins, Dopamine, Dwarfism, Hypothalamus, Membrane Glycoproteins, Mice, Mutant Strains, Nerve Tissue Proteins, Pituitary Diseases, Pituitary Gland, Anterior, In Situ Hybridization, Membrane Transport Proteins, Dopamine Plasma Membrane Transport Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review